Abiopharma

🔍 Cao Haiyun (Director)

Company: JinkoSolar Holding Co., Ltd. (JKS)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 354,285 shares of Ordinary Shares (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 354,285.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By HY Vision Cloud Holdings Limited | shares_owned_after: 1,966,564.00
• Holds 0 shares of Ordinary Shares (represented by American Depositary Shares) (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By Vision Cloud Limited | shares_owned_after: 4,000.00 | Footnotes: F2, F3

Footnotes:

• F1: Vesting of performance-based restricted shares. Each restricted share represents a contingent right to receive one ordinary share of the Issuer. These performance-based restricted shares were granted by the Issuer on January 5, 2023 pursuant to 2023 Equity Incentive Plan, which vested in full on May 1, 2026. These performance-based restricted shares are being reported for the first time on this Form 4 in connection with their vesting.
• F2: Each American Depositary Share ("ADS") represents four ordinary shares of the Issuer, par value US$0.00002 per share.
• F3: Represents previously reported ADSs.